Markus Follmann

1.2k total citations
24 papers, 433 citations indexed

About

Markus Follmann is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Markus Follmann has authored 24 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 5 papers in Oncology. Recurrent topics in Markus Follmann's work include Clinical practice guidelines implementation (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Markus Follmann is often cited by papers focused on Clinical practice guidelines implementation (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Markus Follmann collaborates with scholars based in Germany, United States and Austria. Markus Follmann's co-authors include Klaus‐Dietrich Wolff, Alexander Nast, Hendrik Huppertz, Barbara Buchberger, Guido Skipka, Hanna Kirchner, Beate Fuchs, Wolfgang Linz, Gerhard Heßler and Matthias Löhn and has published in prestigious journals such as British Journal of Pharmacology, Journal of Investigative Dermatology and BMC Medical Research Methodology.

In The Last Decade

Markus Follmann

20 papers receiving 425 citations

Peers

Markus Follmann
In Sun Kwon South Korea
Catherine Rennie United Kingdom
J Jézéquel France
P. B. Thearle
Cliona Lorton Ireland
Carmine Alfano Italy
Kensuke Fukumitsu Japan
Harold S. Nelson United States
Angelantonio Maglio Italy
Liping Wu China
In Sun Kwon South Korea
Markus Follmann
Citations per year, relative to Markus Follmann Markus Follmann (= 1×) peers In Sun Kwon

Countries citing papers authored by Markus Follmann

Since Specialization
Citations

This map shows the geographic impact of Markus Follmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Follmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Follmann more than expected).

Fields of papers citing papers by Markus Follmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Follmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Follmann. The network helps show where Markus Follmann may publish in the future.

Co-authorship network of co-authors of Markus Follmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Follmann. A scholar is included among the top collaborators of Markus Follmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Follmann. Markus Follmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bitzer, Michael, Susanne Blödt, Nadine Fischer, et al.. (2025). Leitlinienreport der S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome“. Zeitschrift für Gastroenterologie. 63(3). e261–e293.
2.
Vilz, Tim O., S. Post, Thomas Langer, et al.. (2024). Recommendations for the perioperative management of pancreatic and colorectal cancer patients. Deutsches Ärzteblatt international. 121(20). 681–687.
3.
Breitbart, Eckhard W., et al.. (2023). S3-Leitlinie Prävention von Hautkrebs: Evaluation und Aktualisierungsprozess. Die Dermatologie. 74(4). 262–269.
4.
Piechotta, Vanessa, Nina Kreuzberger, Ina Monsef, et al.. (2023). The effectiveness of clinical guideline implementation strategies in oncology—a systematic review. BMC Health Services Research. 23(1). 347–347. 11 indexed citations
5.
Bitzer, Michael, Susanne Blödt, Markus Follmann, et al.. (2023). Leitlinienreport der S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms und biliärer Karzinome – Version 3.0 – Juli 2022, AWMF-Registernummer: 032/053OL. Zeitschrift für Gastroenterologie. 61(4). e157–e171. 4 indexed citations
6.
Langer, Thomas, et al.. (2021). Controversial Trials First: Identifying Disagreement Between Clinical Guidelines and New Evidence.. PubMed. 2021. 237–246. 2 indexed citations
7.
Bröckelmann, Paul J., et al.. (2018). Hodgkin Lymphoma in Adults. Deutsches Ärzteblatt international. 115(31-32). 535–540. 18 indexed citations
8.
Doehn, Christian, et al.. (2016). The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma. Deutsches Ärzteblatt international. 113(35-36). 590–6. 22 indexed citations
9.
Wirz, Stefan, Thomas Frieling, Claudia Bausewein, et al.. (2016). Obstipation bei Patienten mit nicht-heilbarer Krebserkrankung. DMW - Deutsche Medizinische Wochenschrift. 141(16). 1177–1181. 1 indexed citations
10.
Petrarca, Sonia, Markus Follmann, Eckhard W. Breitbart, & Sandra Nolte. (2013). Critical Appraisal of Clinical Practice Guidelines for Adaptation in the Evidence-Based Guideline “Prevention of Skin Cancer”. JAMA Dermatology. 149(4). 466–466. 5 indexed citations
11.
Wolff, Klaus‐Dietrich, Markus Follmann, & Alexander Nast. (2012). The Diagnosis and Treatment of Oral Cavity Cancer. Deutsches Ärzteblatt international. 109(48). 829–35. 154 indexed citations
12.
Buchberger, Barbara, et al.. (2011). The Evidence for the Use of Growth Factors and Active Skin Substitutes for the Treatment of Non-Infected Diabetic Foot Ulcers (DFU): A Health Technology Assessment (HTA). Experimental and Clinical Endocrinology & Diabetes. 119(8). 472–479. 29 indexed citations
13.
Buchberger, Barbara, et al.. (2010). The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers. PubMed. 6. Doc12–Doc12. 20 indexed citations
14.
Buchberger, Barbara, Markus Follmann, Hendrik Huppertz, & Jürgen Wasem. (2010). Health technology assessment (HTA) on the importance of growth factors for the treatment of diabetic foot ulcers (DFU). Das Gesundheitswesen. 72(08/09). 1 indexed citations
15.
Follmann, Markus, et al.. (2007). Developing search strategies for clinical practice guidelines in SUMSearch and Google Scholar and assessing their retrieval performance. BMC Medical Research Methodology. 7(1). 28–28. 28 indexed citations
16.
Follmann, Markus & Berthold Rzany. (2005). Development of the German Evidence Based Guideline on the Treatment of Plaque Psoriasis. Journal of Investigative Dermatology. 125(4). 854–854. 1 indexed citations
17.
18.
Follmann, Markus, Wolfram Sterry, & Berthold Rzany. (2004). Leitlinien in der Dermatologie. Aktuelle Dermatologie. 30(7). 263–266. 2 indexed citations
19.
Follmann, Markus, et al.. (2000). Dynamic thermography of the knee joints in rheumatoid arthritis (RA) in the course of the first therapy of the patient with methylprednisolone. Zeitschrift für Rheumatologie. 59(S2). 131–135. 12 indexed citations
20.
Hoffmann, Jörg, Dirk O. Stichtenoth, H. Zeidler, et al.. (1995). Lyme disease in a 74‐year‐old forest owner with symptoms of dermatomyositis. Arthritis & Rheumatism. 38(8). 1157–1160. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by In Sun Kwon Breakdown of academic impact, for papers by Catherine Rennie Breakdown of academic impact, for papers by J Jézéquel Breakdown of academic impact, for papers by P. B. Thearle Breakdown of academic impact, for papers by Cliona Lorton Breakdown of academic impact, for papers by Carmine Alfano Breakdown of academic impact, for papers by Kensuke Fukumitsu Breakdown of academic impact, for papers by Harold S. Nelson Breakdown of academic impact, for papers by Angelantonio Maglio Breakdown of academic impact, for papers by Liping Wu
Rankless by CCL
2026